119th (2025–2027)
H.R. 9090
H.R. 9090, the Advancing Menopause Care and Mid-Life Women's Health Act, directs the National Institutes of Health and the Department of Health and Human Services to expand research on menopause and mid-life women's health, including studies on symptoms, treatments, and health disparities affecting women during perimenopause, menopause, and postmenopause. The bill authorizes $25 million annually through 2031 to support biomedical research, clinical studies, and the establishment of Centers of Excellence that will develop and distribute evidence-based treatment resources to healthcare providers and patients, with priority given to centers serving rural and medically underserved areas. The legislation also requires research on how menopausal symptoms affect women in the workplace and mandates coordination across federal agencies including Veterans Affairs and the Defense Department to ensure integrated efforts and avoid duplicating programs. This comprehensive approach aims to improve both the care and understanding of menopause-related health issues affecting millions of American women.